Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by Pandoraon Oct 24, 2023 6:38pm
130 Views
Post# 35699183

Patent Info

Patent Info
Seems the patent application for the probe has been stymied by an examiner again. It got a Notice of Publication way back on June 24, 2021. It got it's first rejection on September 7, 2021. A lot of back and forth and arguments about the claims through 2021 and the first half of 2022 but ended with a final rejection on August 8, 2022. More discussion and debate in October 2022 and February 2023 culminating with another non-final rejection on February 28, 2023. It got resucitated in August 2023 with a request for an extension of time and new amendments to the claims for reconsideration. This appears to have ended once again with another final rejection as shown below. It seems no matter how hard they try the Inventor and the Examiner cannot come to terms on this. Whether it will be abandoned at this point or whether they will go another round is anybody's guess but it is at least grounded once again in the near term.

16/757,755 | 0822-053796:

DEVICE, SYSTEM AND/OR METHOD FOR POSITION TRACKING

Public view
Application #

16/757,755

Confirmation #

6458

Attorney Docket #

0822-053796

Patent #

-

Filing or 371 (c) date

04/20/2020

Status

Final Rejection Counted, Not Yet Mailed 10/22/2023


<< Previous
Bullboard Posts
Next >>